
home All News open_in_new Full Article
Life in the old dog yet: how biotech firms are looking to extend the lives of our pets

Biotech firms are working to extend the lifespans of pets, particularly dogs, with one startup, Loyal, securing $150 million in investment to develop a lifespan-extension drug. Loyal's research focuses on larger dog breeds' shorter lifespans and aims to develop vet-prescribed products that reduce IGF-1, a hormone linked to cell growth and potentially cancer. They have three drugs in development, with one targeting older dogs nearing FDA approval.
today 54 h. ago attach_file Politics
attach_file
Politics
attach_file
Events
attach_file
Economics
attach_file
Events
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Sport
attach_file
Politics
attach_file
Politics
attach_file
Science
attach_file
Politics
attach_file
Economics
attach_file
Events
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Economics
ID: 301254381